ZA944034B - Delta6 7-taxols antineoplastic use and pharmaceutical compositions containing them - Google Patents

Delta6 7-taxols antineoplastic use and pharmaceutical compositions containing them

Info

Publication number: ZA944034B
Authority: ZA; South Africa
Prior art keywords: substd; opt; nhcoocme3; substits; succinyl
Prior art date: 1993-06-11

Application number

ZA944034A

Other languages

English (en)

Inventor

Robert C Kelly

Harvey L Skulnick

Roy A Johnson

Eldon G Nidy

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-06-11

Filing date

1994-06-08

Publication date

1995-12-08

1993-12-13 Priority claimed from PCT/US1993/011827 external-priority patent/WO1994013655A1/en

1994-06-08 Application filed by Upjohn Co filed Critical Upjohn Co

1995-12-08 Publication of ZA944034B publication Critical patent/ZA944034B/xx

Links

230000000118 anti-neoplastic effect Effects 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
-1 amino, p-toluene-sulphonamido Chemical group 0.000 abstract 5
150000007513 acids Chemical class 0.000 abstract 3
125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 3
OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 abstract 2
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 abstract 2
125000001475 halogen functional group Chemical group 0.000 abstract 2
125000002030 1,2-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([*:2])C([H])=C1[H] 0.000 abstract 1
KNWCDYSKJSREAQ-UHFFFAOYSA-N 1,3-oxazolidine-2-carboxylic acid Chemical class OC(=O)C1NCCO1 KNWCDYSKJSREAQ-UHFFFAOYSA-N 0.000 abstract 1
125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 abstract 1
125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 1
125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 abstract 1
125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 abstract 1
SBQWITJAJITAMM-UHFFFAOYSA-N 4-oxo-4-(2-sulfoethylamino)butanoic acid Chemical compound OC(=O)CCC(=O)NCCS(O)(=O)=O SBQWITJAJITAMM-UHFFFAOYSA-N 0.000 abstract 1
101100173726 Arabidopsis thaliana OR23 gene Proteins 0.000 abstract 1
229930012538 Paclitaxel Natural products 0.000 abstract 1
229910006069 SO3H Inorganic materials 0.000 abstract 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 abstract 1
125000002905 alkanoylamido group Chemical group 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
125000005281 alkyl ureido group Chemical group 0.000 abstract 1
229930014667 baccatin III Natural products 0.000 abstract 1
150000003935 benzaldehydes Chemical class 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
230000020176 deacylation Effects 0.000 abstract 1
238000005947 deacylation reaction Methods 0.000 abstract 1
125000004663 dialkyl amino group Chemical group 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
229960001592 paclitaxel Drugs 0.000 abstract 1
125000005544 phthalimido group Chemical group 0.000 abstract 1
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA944034A 1993-06-11 1994-06-08 Delta6 7-taxols antineoplastic use and pharmaceutical compositions containing them ZA944034B (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US7633793A	1993-06-11	1993-06-11
US12297493A	1993-09-17	1993-09-17
PCT/US1993/011827 WO1994013655A1 (en)	1992-12-15	1993-12-13	7-HALO- AND 7β,8β-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number	Publication Date
ZA944034B true ZA944034B (en)	1995-12-08

Family

ID=26757982

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA944034A ZA944034B (en)	1993-06-11	1994-06-08	Delta6 7-taxols antineoplastic use and pharmaceutical compositions containing them

Country Status (18)

Country	Link
US (2)	US5965739A (de)
EP (3)	EP0982301B1 (de)
JP (1)	JPH09511212A (de)
AT (3)	ATE192147T1 (de)
AU (1)	AU7138894A (de)
CA (1)	CA2161328A1 (de)
DE (3)	DE69433146T2 (de)
DK (3)	DK0982302T3 (de)
ES (3)	ES2205663T3 (de)
GR (1)	GR3033836T3 (de)
IL (1)	IL109957A (de)
LV (2)	LV12692B (de)
NZ (2)	NZ330671A (de)
PT (3)	PT982301E (de)
SI (2)	SI0703909T1 (de)
TW (1)	TW401407B (de)
WO (1)	WO1994029288A1 (de)
ZA (1)	ZA944034B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5998656A (en) *	1991-09-23	1999-12-07	Florida State University	C10 tricyclic taxanes
FR2696460B1 (fr) *	1992-10-05	1994-11-25	Rhone Poulenc Rorer Sa	Procédé de préparation de dérivés du taxane.
FR2697522B1 (fr) *	1992-10-30	1994-11-25	Rhone Poulenc Rorer Sa	Procédé de préparation de dérivés du taxane.
US5380751A (en) *	1992-12-04	1995-01-10	Bristol-Myers Squibb Company	6,7-modified paclitaxels
CA2109861C (en) *	1992-12-04	1999-03-16	Shu-Hui Chen	6,7-modified paclitaxels
FR2721026B1 (fr) *	1994-06-09	1996-07-12	Rhone Poulenc Rorer Sa	Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2721025B1 (fr) *	1994-06-09	1996-07-12	Rhone Poulenc Rorer Sa	Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
IT1275936B1 (it) *	1995-03-17	1997-10-24	Indena Spa	Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
CA2170661A1 (en) *	1995-03-22	1996-09-23	John K. Thottathil	Novel methods for the preparation of taxanes using oaxzolidine intermediates
US5780653A (en) *	1995-06-07	1998-07-14	Vivorx Pharmaceuticals, Inc.	Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
ATE223889T1 (de)	1996-05-08	2002-09-15	Upjohn Co	Oxazolidinester
EP1114815B1 (de) *	1996-05-08	2004-09-29	PHARMACIA & UPJOHN COMPANY	Verfahren zu Herstellung von Taxol
DE69734060T2 (de)	1996-05-24	2006-06-29	Angiotech Pharmaceuticals, Inc., Vancouver	Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
US5977386A (en) *	1996-12-24	1999-11-02	Bristol-Myers Squibb Company	6-thio-substituted paclitaxels
US5912264A (en) *	1997-03-03	1999-06-15	Bristol-Myers Squibb Company	6-halo-or nitrate-substituted paclitaxels
US5837283A (en) *	1997-03-12	1998-11-17	The Regents Of The University Of California	Cationic lipid compositions targeting angiogenic endothelial cells
US7112338B2 (en) *	1997-03-12	2006-09-26	The Regents Of The University Of California	Cationic liposome delivery of taxanes to angiogenic blood vessels
US6017935A (en) *	1997-04-24	2000-01-25	Bristol-Myers Squibb Company	7-sulfur substituted paclitaxels
US6150537A (en) *	1997-12-12	2000-11-21	Emory University	Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents
US6235782B1 (en)	1998-11-12	2001-05-22	Rifat Pamukcu	Method for treating a patient with neoplasia by treatment with a platinum coordination complex
US6235776B1 (en)	1998-11-12	2001-05-22	Cell Pathways, Inc.	Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
KR100591767B1 (ko) *	1999-09-09	2006-06-23	더 리젠츠 오브 더 유니버시티 오브 캘리포니아	탁산의 맥관형성 혈관 전달을 위한 양이온성 리포좀
AU775373B2 (en)	1999-10-01	2004-07-29	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6414015B1 (en) *	2000-01-28	2002-07-02	Utah State University	Laulimalide microtubule stabilizing agents
US6649632B2 (en)	2000-02-02	2003-11-18	Fsu Research Foundation, Inc.	C10 ester substituted taxanes
US6596737B2 (en)	2000-02-02	2003-07-22	Fsu Research Foundation, Inc.	C10 carbamoyloxy substituted taxanes
NZ514406A (en)	2000-02-02	2005-01-28	Univ Florida State Res Found	C10 heterosubstituted acetate taxanes as antitumor agents
TR200102857T1 (tr)	2000-02-02	2002-06-21	Florida State University Research Foundation Inc.	Antitümör ajanları olarak C7 karbonat ikameli taksanlar
CO5280224A1 (es) *	2000-02-02	2003-05-30	Univ Florida State Res Found	Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
JP2003522171A (ja)	2000-02-02	2003-07-22	フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド	抗腫瘍剤としてのｃ１０カーボネート置換タキサン
US6362217B2 (en)	2000-03-17	2002-03-26	Bristol-Myers Squibb Company	Taxane anticancer agents
CA2410632A1 (en)	2000-06-22	2001-12-27	David S. Garvey	Nitrosated and nitrosylated taxanes, compositions and methods of use
CZ2003837A3 (cs) *	2000-09-22	2004-12-15	Bristol-Myers Squibb Company	Způsob pro snížení toxicity při kombinovaných chemoterapiích
AU2002249958B2 (en)	2001-01-16	2007-11-08	Vascular Therapies, Inc.	Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
DE60144113D1 (de) *	2001-03-23	2011-04-07	Scinopharm Taiwan Ltd	Verfahren zur herstellung von taxanderivaten
CA2354478A1 (en) *	2001-07-31	2003-01-31	Florida State University Research Foundation, Inc.	C10 carbonate substituted taxanes
US20040132991A1 (en) *	2002-10-09	2004-07-08	Phytogen Life Sciences Inc.	Novel taxanes and methods related to use and preparation thereof
US7064980B2 (en) *	2003-09-17	2006-06-20	Sandisk Corporation	Non-volatile memory and method with bit line coupled compensation
HN2005000054A (es) *	2004-02-13	2009-02-18	Florida State University Foundation Inc	Taxanos sustituidos con esteres de ciclopentilo en c10
EP1737444A4 (de)	2004-03-05	2008-05-21	Univ Florida State Res Found	C7-lactyloxa-substituierte taxane
JP2008530122A (ja) *	2005-02-14	2008-08-07	フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド	Ｃ１０シクロプロピルエステル置換タキサン組成物
WO2007075870A2 (en) *	2005-12-21	2007-07-05	Tapestry Pharmaceuticals, Inc.	Processes for taxane derivatives and intermediates useful therein
ITMI20062479A1 (it) *	2006-12-21	2008-06-22	Indena Spa	Processo per la preparazione di secotassani
EP2080764B1 (de)	2008-01-18	2012-08-22	INDENA S.p.A.	Feste Formen von Ortataxel
JP2011517455A (ja) *	2008-03-31	2011-06-09	フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド	Ｃ（１０）エチルエステルおよびｃ（１０）シクロプロピルエステル置換タキサン
WO2011134067A1 (en) *	2010-04-29	2011-11-03	6570763 Canada Inc.	Novel amino acid molecule and uses thereof
CN101863862B (zh) *	2010-06-18	2012-01-11	云南汉德生物技术有限公司	一种工业半合成紫杉醇的方法
CN103980232A (zh) *	2014-06-05	2014-08-13	北京诺普德医药科技有限公司	10-乙酰基多西紫杉醇及其用途
CN111138386A (zh) *	2019-12-30	2020-05-12	重庆市碚圣医药科技股份有限公司	一种多西他赛的半合成方法
CN115260130A (zh) *	2022-07-07	2022-11-01	上海卓鼎生物技术有限公司	一种10-脱乙酰基紫杉醇的制备方法
CN116462643B (zh) *	2023-03-29	2025-04-15	无锡贝塔医药科技有限公司	一种氘标记的多西他赛的合成方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2601676B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Procede de preparation du taxol et du desacetyl-10 taxol
FR2601675B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4876399A (en) *	1987-11-02	1989-10-24	Research Corporation Technologies, Inc.	Taxols, their preparation and intermediates thereof
US5157049A (en) *	1988-03-07	1992-10-20	The United States Of America As Represented By The Department Of Health & Human Services	Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
US4942184A (en) *	1988-03-07	1990-07-17	The United States Of America As Represented By The Department Of Health And Human Services	Water soluble, antineoplastic derivatives of taxol
FR2629819B1 (fr) *	1988-04-06	1990-11-16	Rhone Poulenc Sante	Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
FR2629818B1 (fr) *	1988-04-06	1990-11-16	Centre Nat Rech Scient	Procede de preparation du taxol
EP0366841A1 (de) *	1988-11-03	1990-05-09	Dresser-Rand Company	Kreuzkopf und Kreuzkopfzapfenbefestigung
US4960790A (en) *	1989-03-09	1990-10-02	University Of Kansas	Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) *	1989-05-31	1992-12-29	Florida State University	Method for preparation of taxol using β-lactam
CA2023645C (fr) *	1989-08-23	2002-03-26	Jean-Noel Denis	Procede pour la preparation enantioselective de derives de la phenylisoserine
US5136060A (en) *	1989-11-14	1992-08-04	Florida State University	Method for preparation of taxol using an oxazinone
US5015744A (en) *	1989-11-14	1991-05-14	Florida State University	Method for preparation of taxol using an oxazinone
FR2658513B1 (fr) *	1990-02-21	1994-02-04	Rhone Poulenc Sante	Procede de preparation de l'acide cis-beta-phenylglycidique-(2r,3r).
FR2658510B1 (fr) *	1990-02-21	1992-04-30	Rhone Poulenc Sante	Nouveau derive de la beta-phenylisoserine, sa preparation et son emploi.
FR2662440B1 (fr) *	1990-05-22	1992-07-31	Rhone Poulenc Sante	Procede de preparation stereoselective de derives de la phenylisoserine.
FR2662441B1 (fr) *	1990-05-22	1992-10-23	Rhone Poulenc Sante	Procede de preparation enantioselective de derives de la phenylisoserine.
US5059699A (en) *	1990-08-28	1991-10-22	Virginia Tech Intellectual Properties, Inc.	Water soluble derivatives of taxol
MX9102128A (es) *	1990-11-23	1992-07-08	Rhone Poulenc Rorer Sa	Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2679230B1 (fr) *	1991-07-16	1993-11-19	Rhone Poulenc Rorer Sa	Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
US5227400A (en) *	1991-09-23	1993-07-13	Florida State University	Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5250683A (en) *	1991-09-23	1993-10-05	Florida State University	Certain substituted taxanes and pharmaceutical compositions containing them
FR2687151B1 (fr) *	1992-02-07	1994-03-25	Rhone Poulenc Rorer Sa	Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5248796A (en) *	1992-06-18	1993-09-28	Bristol-Myers Squibb Company	Taxol derivatives
US5294637A (en) *	1992-07-01	1994-03-15	Bristol-Myers Squibb Company	Fluoro taxols
ATE256115T1 (de) *	1992-07-01	2003-12-15	Bristol Myers Squibb Co	7,8-zyklopropataxanen mit antitumor wirkung
US5254580A (en) *	1993-01-19	1993-10-19	Bristol-Myers Squibb Company	7,8-cyclopropataxanes
FR2696460B1 (fr) *	1992-10-05	1994-11-25	Rhone Poulenc Rorer Sa	Procédé de préparation de dérivés du taxane.
FR2696464B1 (fr) *	1992-10-05	1994-11-10	Rhone Poulenc Rorer Sa	Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
FR2696458B1 (fr) *	1992-10-05	1994-11-10	Rhone Poulenc Rorer Sa	Procédé de préparation de dérivés du taxane.
FR2696459B1 (fr) *	1992-10-05	1994-11-25	Rhone Poulenc Rorer Sa	Procédé de préparation de dérivés du taxane.
FR2697522B1 (fr) *	1992-10-30	1994-11-25	Rhone Poulenc Rorer Sa	Procédé de préparation de dérivés du taxane.
CA2109861C (en) *	1992-12-04	1999-03-16	Shu-Hui Chen	6,7-modified paclitaxels
US5380751A (en) *	1992-12-04	1995-01-10	Bristol-Myers Squibb Company	6,7-modified paclitaxels
FR2698871B1 (fr) *	1992-12-09	1995-02-24	Rhone Poulenc Rorer Sa	Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.

1994
- 1994-06-03 ES ES99118033T patent/ES2205663T3/es not_active Expired - Lifetime
- 1994-06-03 DE DE69433146T patent/DE69433146T2/de not_active Expired - Fee Related
- 1994-06-03 CA CA002161328A patent/CA2161328A1/en not_active Abandoned
- 1994-06-03 NZ NZ330671A patent/NZ330671A/xx unknown
- 1994-06-03 WO PCT/US1994/006035 patent/WO1994029288A1/en not_active Ceased
- 1994-06-03 EP EP99118033A patent/EP0982301B1/de not_active Expired - Lifetime
- 1994-06-03 AT AT94920688T patent/ATE192147T1/de not_active IP Right Cessation
- 1994-06-03 SI SI9430317T patent/SI0703909T1/xx unknown
- 1994-06-03 PT PT99118033T patent/PT982301E/pt unknown
- 1994-06-03 EP EP94920688A patent/EP0703909B1/de not_active Expired - Lifetime
- 1994-06-03 PT PT94920688T patent/PT703909E/pt unknown
- 1994-06-03 SI SI9430464T patent/SI0982302T1/xx unknown
- 1994-06-03 DK DK99118034T patent/DK0982302T3/da active
- 1994-06-03 US US08/557,034 patent/US5965739A/en not_active Expired - Fee Related
- 1994-06-03 DE DE69424166T patent/DE69424166T2/de not_active Expired - Fee Related
- 1994-06-03 DK DK99118033T patent/DK0982301T3/da active
- 1994-06-03 ES ES99118034T patent/ES2219968T3/es not_active Expired - Lifetime
- 1994-06-03 DE DE69433715T patent/DE69433715T2/de not_active Expired - Fee Related
- 1994-06-03 PT PT99118034T patent/PT982302E/pt unknown
- 1994-06-03 NZ NZ268475A patent/NZ268475A/en unknown
- 1994-06-03 DK DK94920688T patent/DK0703909T3/da active
- 1994-06-03 JP JP7501878A patent/JPH09511212A/ja not_active Ceased
- 1994-06-03 ES ES94920688T patent/ES2145829T3/es not_active Expired - Lifetime
- 1994-06-03 EP EP99118034A patent/EP0982302B1/de not_active Expired - Lifetime
- 1994-06-03 AU AU71388/94A patent/AU7138894A/en not_active Abandoned
- 1994-06-03 AT AT99118033T patent/ATE249448T1/de not_active IP Right Cessation
- 1994-06-03 AT AT99118034T patent/ATE264316T1/de not_active IP Right Cessation
- 1994-06-08 ZA ZA944034A patent/ZA944034B/xx unknown
- 1994-06-09 IL IL10995794A patent/IL109957A/en not_active IP Right Cessation
- 1994-06-09 TW TW083105245A patent/TW401407B/zh not_active IP Right Cessation
- 1994-06-10 US US08/258,019 patent/US5556878A/en not_active Expired - Fee Related
2000
- 2000-06-30 GR GR20000401537T patent/GR3033836T3/el not_active IP Right Cessation
2001
- 2001-04-26 LV LV010064A patent/LV12692B/xx unknown
2005
- 2005-04-14 LV LVP-05-45A patent/LV13319B/en unknown

Also Published As

Publication number	Publication date
NZ268475A (en)	1998-08-26
DK0982302T3 (da)	2004-08-02
IL109957A (en)	2001-01-11
DK0703909T3 (da)	2000-09-11
EP0703909B1 (de)	2000-04-26
DK0982301T3 (da)	2003-12-08
DE69433146T2 (de)	2004-06-09
EP0982301A3 (de)	2000-11-08
IL109957A0 (en)	1994-10-07
DE69433146D1 (de)	2003-10-16
EP0982302A3 (de)	2000-07-19
LV12692B (lv)	2001-09-20
GR3033836T3 (en)	2000-10-31
LV12692A (lv)	2001-07-20
JPH09511212A (ja)	1997-11-11
ES2219968T3 (es)	2004-12-01
DE69424166T2 (de)	2000-10-05
WO1994029288A1 (en)	1994-12-22
AU7138894A (en)	1995-01-03
DE69433715D1 (de)	2004-05-19
ATE264316T1 (de)	2004-04-15
ES2205663T3 (es)	2004-05-01
US5556878A (en)	1996-09-17
DE69424166D1 (de)	2000-05-31
DE69433715T2 (de)	2005-03-24
LV13319B (en)	2005-08-20
EP0982302B1 (de)	2004-04-14
ATE249448T1 (de)	2003-09-15
NZ330671A (en)	2000-01-28
EP0982301B1 (de)	2003-09-10
ES2145829T3 (es)	2000-07-16
EP0982302A2 (de)	2000-03-01
PT703909E (pt)	2000-10-31
SI0982302T1 (en)	2004-08-31
PT982302E (pt)	2004-07-30
EP0982301A2 (de)	2000-03-01
SI0703909T1 (en)	2000-08-31
PT982301E (pt)	2004-02-27
ATE192147T1 (de)	2000-05-15
TW401407B (en)	2000-08-11
EP0703909A1 (de)	1996-04-03
CA2161328A1 (en)	1994-12-22
US5965739A (en)	1999-10-12

Publication	Publication Date	Title
ZA944034B (en)	1995-12-08	Delta6 7-taxols antineoplastic use and pharmaceutical compositions containing them
SE9102462D0 (sv)	1991-08-28	New isosteric peptides
DE59706313D1 (de)	2002-03-21	Acylierte n-hydroxymethyl thalidomid-prodrugs mit immunomodulatorischer wirkung
MY102219A (en)	1992-05-15	Leukotriene antagonists
FI905943A0 (fi)	1990-12-03	Isotinderivat, deras framstaellning och anvaendning.
FI932683A0 (fi)	1993-06-11	Skoetselmedel foer haorda och mjuka kontaktlinser
DE68925540D1 (de)	1996-03-14	Peptid-Antibiotika
DE3666223D1 (en)	1989-11-16	Anticonvulsant agents
RU97105810A (ru)	1999-04-10	Адъюванты
DE3675431D1 (de)	1990-12-13	1,3-oxathianderivate.
ES8506722A1 (es)	1985-08-01	Un procedimiento para la preparacion de derivados de -lactama
JPS56142260A (en)	1981-11-06	2-azetidinone and its preparation
ATE95172T1 (de)	1993-10-15	Cyclopropanthiocarbonsaeureamide.
NO20004774L (no)	2000-09-25	Alifatiske aminokarboksyl- og aminofosfonsyrer, aminonitriler og aminotetrazoler som cellulære redningsmidler
JPS5731648A (en)	1982-02-20	Pentapeptide derivative
TH50956A3 (th)	2002-05-10	อนุพันธ์ฟีนิลไกลซีน